CMO/CDMO Biotechnology Market Size, Share, and Growth Forecast, 2025 - 2032

Table of Content

1. Executive Summary
   1. Global CMO/CDMO Biotechnology Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Product Type Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Tool Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
4. Price Analysis, 2024A
   1. Key Highlights
   2. Key Factors Impacting Deployment Costs
   3. Pricing Analysis, By Product Type
5. Global CMO/CDMO Biotechnology Market Outlook
   1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
   3. Global CMO/CDMO Biotechnology Market Outlook: Service Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Service Type, 2019 - 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Service Type, 2025 - 2032
         1. Standalone Services
         2. Integrated Contract Development & Manufacturing Services
         3. Contract Manufacturing Services
      4. Market Attractiveness Analysis: Service Type
   4. Global CMO/CDMO Biotechnology Market Outlook: Product Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 - 2032
         1. Monoclonal Antibodies
         2. Cell & Gene Therapies (CGTs)
         3. Advanced Therapy Medicinal Products (ATMPs)
         4. Others
      4. Market Attractiveness Analysis: Product Type
   5. Global CMO/CDMO Biotechnology Market Outlook: Scale of Operation
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Scale of Operation, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Scale of Operation, 2025 - 2032
         1. Small Scale/Pilot Production
         2. Large Scale/Commercial Manufacturing
      4. Market Attractiveness Analysis: Scale of Operation
6. Global CMO/CDMO Biotechnology Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
   3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
7. North America CMO/CDMO Biotechnology Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Service Type
      3. By Product Type
      4. By Scale of Operation
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Service Type, 2025 - 2032
      1. Standalone Services
      2. Integrated Contract Development & Manufacturing Services
      3. Contract Manufacturing Services
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Monoclonal Antibodies
      2. Cell & Gene Therapies (CGTs)
      3. Advanced Therapy Medicinal Products (ATMPs)
      4. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By Scale of Operation, 2025-2032
      1. Small Scale/Pilot Production
      2. Large Scale/Commercial Manufacturing
   7. Market Attractiveness Analysis
8. Europe CMO/CDMO Biotechnology Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Service Type
      3. By Product Type
      4. Scale of Operation
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Service Type, 2025 - 2032
      1. Standalone Services
      2. Integrated Contract Development & Manufacturing Services
      3. Contract Manufacturing Services
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Monoclonal Antibodies
      2. Cell & Gene Therapies (CGTs)
      3. Advanced Therapy Medicinal Products (ATMPs)
      4. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By Scale of Operation, 2025-2032
      1. Small Scale/Pilot Production
      2. Large Scale/Commercial Manufacturing
   7. Market Attractiveness Analysis
9. East Asia CMO/CDMO Biotechnology Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Service Type
      3. By Product Type
      4. By Scale of Operation
   3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Service Type, 2025 - 2032
      1. Standalone Services
      2. Integrated Contract Development & Manufacturing Services
      3. Contract Manufacturing Services
   5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 - 2032
      1. Monoclonal Antibodies
      2. Cell & Gene Therapies (CGTs)
      3. Advanced Therapy Medicinal Products (ATMPs)
      4. Others
   6. Current Market Size (US$ Bn) Analysis and Forecast, By Scale of Operation, 2025-2032
      1. Small Scale/Pilot Production
      2. Large Scale/Commercial Manufacturing
   7. Market Attractiveness Analysis
10. South Asia & Oceania CMO/CDMO Biotechnology Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Service Type
       3. By Product Type
       4. By Scale of Operation
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. India
       2. Southeast Asia
       3. ANZ
       4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Service Type, 2025 - 2032
       1. Standalone Services
       2. Integrated Contract Development & Manufacturing Services
       3. Contract Manufacturing Services
    5. ICurrent Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 - 2032
       1. Monoclonal Antibodies
       2. Cell & Gene Therapies (CGTs)
       3. Advanced Therapy Medicinal Products (ATMPs)
       4. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Scale of Operation, 2025-2032
       1. Small Scale/Pilot Production
       2. Large Scale/Commercial Manufacturing
    7. Market Attractiveness Analysis
11. Latin America CMO/CDMO Biotechnology Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Service Type
       3. By Product Type
       4. By Scale of Operation
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Service Type, 2025 - 2032
       1. Standalone Services
       2. Integrated Contract Development & Manufacturing Services
       3. Contract Manufacturing Services
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 - 2032
       1. Monoclonal Antibodies
       2. Cell & Gene Therapies (CGTs)
       3. Advanced Therapy Medicinal Products (ATMPs)
       4. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Scale of Operation, 2025-2032
       1. Small Scale/Pilot Production
       2. Large Scale/Commercial Manufacturing
    7. Market Attractiveness Analysis
12. Middle East & Africa CMO/CDMO Biotechnology Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Service Type
       3. By Product Type
       4. By Scale of Operation
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Service Type, 2025 - 2032
       1. Standalone Services
       2. Integrated Contract Development & Manufacturing Services
       3. Contract Manufacturing Services
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 - 2032
       1. Monoclonal Antibodies
       2. Cell & Gene Therapies (CGTs)
       3. Advanced Therapy Medicinal Products (ATMPs)
       4. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Scale of Operation, 2025-2032
       1. Small Scale/Pilot Production
       2. Large Scale/Commercial Manufacturing
    7. Market Attractiveness Analysis
13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Lonza Group AG
          1. Overview
          2. Segments and Deployments
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Thermo Fisher Scientific Inc.
       3. Samsung Biologics Co., Ltd.
       4. Boehringer Ingelheim International GmbH
       5. AGC Biologics, Inc.
       6. WuXi Biologics
       7. Patheon N.V.
       8. Catalent, Inc.
       9. AbbVie Inc.
       10. Avid Bioservices, Inc.
       11. Fujifilm Diosynth Biotechnologies
       12. Rentschler Biopharma SE
       13. KBI Biopharma (JSR Corporation)
       14. Cytovance Biologics
       15. Xpress Biologic
14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations